Gene and Cell Therapy
A section of Biomedicines (ISSN 2227-9059).
Section Information
This section of Biomedicines aims to rapidly publish contributions on all aspects of the latest research results concerning gene and cell therapy. We encourage the submission of manuscripts that provide novel and mechanistic insights and papers that report significant advances on the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Current Trends in Regenerative Medicine (Deadline: 31 May 2025)
- Advances in CAR-T Cell Therapy (Deadline: 30 June 2025)
- Progress in Protein Therapeutics (Deadline: 30 June 2025)
- Advancements in Induced Pluripotent Stem Cells (Deadline: 31 August 2025)
- Emerging Trends in the Study of Inherited Metabolic Disorders (Deadline: 31 August 2025)
- Diagnostic and Therapeutic Challenges of CAR-T Cell Therapy (Deadline: 30 September 2025)
- Skin Diseases and Cell Therapy (Deadline: 30 September 2025)
- Engineering Extracellular Matrix (ECM)-Based Scaffold Biomaterials for Cancer Treatment (Deadline: 30 November 2025)
Topical Collection
Following topical collection within this section is currently open for submissions:
